4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000002
Chairperson & CEO sold 9,500 shares at an average $515.37 ($4,896,019)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
19 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $146.03 | $1,387,285 | 9,630 | D |
| 2026-03-02 | Sale : show line 2 in the form 10b5-1 | −160 | $507.27 | $81,163 | 9,470 | D |
| 2026-03-02 | Sale : show line 3 in the form 10b5-1 | −319 | $508.49 | $162,208 | 9,151 | D |
| 2026-03-02 | Sale : show line 4 in the form 10b5-1 | −427 | $509.66 | $217,625 | 8,724 | D |
| 2026-03-02 | Sale : show line 5 in the form 10b5-1 | −311 | $511.05 | $158,936 | 8,413 | D |
| 2026-03-02 | Sale : show line 6 in the form 10b5-1 | −722 | $511.95 | $369,627 | 7,691 | D |
| 2026-03-02 | Sale : show line 7 in the form 10b5-1 | −1,360 | $512.83 | $697,452 | 6,331 | D |
| 2026-03-02 | Sale : show line 8 in the form 10b5-1 | −1,042 | $514.02 | $535,610 | 5,289 | D |
| Open-market sales · 9,500 sh · avg $515.37 · $4,896,019 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-02 | Exercise or conversion : show line 20 in the form 10b5-1 Stock Option | −9,500 | 230,500 | D |
Loading xslF345X05/primarydocument.xml…